Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian MS Treatment Registry

被引：0
|
作者：
Michael Guger
Christian Enzinger
Fritz Leutmezer
Franziska Di Pauli
Jörg Kraus
Stefan Kalcher
Erich Kvas
Thomas Berger
机构：
[1] Kepler University Hospital GmbH,Clinic for Neurology 2, Med Campus III
[2] Johannes Kepler University Linz,Medical Faculty
[3] Medical University of Graz,Department of Neurology
[4] Medical University of Vienna,Department of Neurology
[5] Medical University of Innsbruck,Clinical Department of Neurology
[6] Paracelsus Medical University and Salzburger Landeskliniken,Department of Laboratory Medicine
[7] Heinrich-Heine-University,Department of Neurology, Medical Faculty
[8] Hermesoft,undefined
[9] Data management,undefined
[10] Hermesoft,undefined
[11] Statistics,undefined
来源：
Journal of Neurology | 2021年 / 268卷
关键词：
Disability progression; Long-term; Multiple sclerosis; Natalizumab; Predictor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4303 / 4310
页数：7
相关论文
共 50 条
  • [41] Corticosteroids for the long-term treatment in multiple sclerosis
    Ciccone, A.
    Beretta, S.
    Brusaferri, F.
    Galea, I
    Protti, A.
    Spreafico, C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [42] LONG-TERM TREATMENT OF MULTIPLE SCLEROSIS WITH CORTICOTROPHIN
    MILLAR, JHD
    VAS, CJ
    NORONHA, MJ
    LIVERSED.LA
    RAWSON, MD
    LANCET, 1967, 2 (7513): : 429 - &
  • [43] LONG-TERM TREATMENT OF MULTIPLE SCLEROSIS WITH CORTICOIDS
    FOG, T
    ACTA NEUROLOGICA SCANDINAVICA, 1965, S 41 : 473 - &
  • [44] Survival: the ultimate long-term outcome in multiple sclerosis
    Giovannoni, Gavin
    BRAIN, 2019, 142 : 1166 - 1167
  • [45] Long-term Antibiotic Treatment with Roxithromycin in Patients with Multiple Sclerosis
    R. Woessner
    M. T. Grauer
    A. Frese
    F. Bethke
    T. Ginger
    A. Hans
    J. Treib
    Infection, 2006, 34 : 342 - 344
  • [46] Long-term antibiotic treatment with roxithromycin in patients with multiple sclerosis
    Woessner, R.
    Grauer, M. T.
    Frese, A.
    Bethke, F.
    Ginger, T.
    Hans, A.
    Treib, J.
    INFECTION, 2006, 34 (06) : 342 - 344
  • [47] Amelanotic Lentigo Maligna Melanoma Associated with Long-Term Natalizumab Treatment for Multiple Sclerosis
    Carter, Jonathan L.
    Connolly, Suzanne M.
    NEUROLOGY, 2010, 74 (09) : A419 - A420
  • [48] Long-term outcomes in patients with multiple sclerosis
    Bates, David
    NEUROLOGY, 2011, 76 (01) : S1 - S2
  • [49] Natalizumab in paediatric multiple sclerosis: long-term results of 55 cases
    Ghezzi, A.
    Pozzilli, C.
    Moiola, L.
    Morra, V. Brescia
    Grimaldi, L. M. E.
    Lus, G.
    Rinaldi, F.
    Rocca, M. A.
    Trojano, M.
    Bianchi, A.
    Filippi, M.
    Comi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 301 - 302
  • [50] Long-term escalation therapy with natalizumab in paediatric and adolescent multiple sclerosis
    Bayas, A.
    Pitarokoili, K.
    Penzien, J.
    Gold, R.
    Hellwig, K.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S70 - S70
12345